McKechnie Duncan sold VRTX
July 2, 2026 · Form 4 insider transaction
McKechnie Duncan sold 1,541 shares of Vertex Pharmaceuticals Incorporated at $519.00 per share, a transaction worth $799.8K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 5 days after the transaction.
Direction
Disposed (sell-side)
Shares
1,541
Price
$519.00
Total value
$799.8K
InsiderMcKechnie Duncan
Role—
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateJuly 2, 2026
Filing dateJuly 7, 2026
Shares owned after11,001
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
Transaction made pursuant to Mr. McKechnie's company approved trading plan under Rule 10b5-1, which was entered into on 11/25/2025.